RAUTOU LAB

Welcome to the Rautou Lab

The team works on the link between the vessels and liver diseases. We are interested in rare vascular liver diseases (Budd-Chiari syndrome, extrahepatic vein thrombosis and porto-sinusoidal vascular disease), nonalcoholic steatohepatitis and cirrhosis.

LATEST NEWS

A new video dedicated to patients, explaining portosinusoidal vascular disorders

Vascular Disorders of the Liver

VALDIG's Guide to Management and Causes

A collective book gathering the experience collected during a 15 yr long cooperation between European centers
Written by world-leading clinical investigators in the field involved
At the interface between highly specialized hepatology and hematology/internal medicine/intensive care/radiology

Dominique Valla, Juan Carlos Garcia-Pagan, Andrea De Gottardi, Pierre-Emmanuel Rautou

Link

Multicenter study on recent portal venous system thrombosis associated with cytomegalovirus disease

Chloé De Broucker et al. - J. Hepatol - 2021
CMV disease triggers for portal vein thrombosis :
=> a special link with factor II gene mutation
=> do not forget to screen for all risk factors for thrombosis
=> no impact on recanalisation.
For more details, please read our paper

EASL TAKEWAYS - Cirrhosis and complications

Discover cirrhosis and complications with Professor Didier Samuel, Professor Andrés Cárdenas and Professor Pierre-Emmanuel Rautou

ERN Rare-Liver on-demand Webinar: Porto sinusoidal vascular disease

Podcast of Prof PE Rautou on porto-sinusoidal vascular disease : link

The International Liver Congress - EASL STUDIO

Prof U Beuers interviews Prof PE Rautou on porto-sinusoidal vascular disease

In the March 2021 issue of "Sciences et vie", multiomics are described in great detail. At this occasion, Prof. Pierre-Emmanuel Rautou explains the approach developed in the European project he coordinates, using omics to improve diagnosis and prognosis of patients with liver diseases :
“C’est pourquoi nous avons lancé avec 20 autres centre européens un vaste projet d’analyse multiomique sur une cohort qui compte déjà 2200 patients.”

Pierre-Emmanuel Rautou and Valerie Paradis obtained an ARC funding for the project "Endothelial autophagy in liver carcinogenesis related to NonAlcoholic Fatty Liver Disease : Role and potential therapeutic target"

Congratulations to Louise Biquard for her great award

EASL Digital ILC 2020 Takeaways - Cirrhosis and complications

The DECISION project coordinated by Prof Rautou
European researchers seek to reduce the number of patients dying from cirrhosis
Visite the website for more informations => here

Information about COVID pandemic in Hepatology Departments

New Publication
A defect in endothelial autophagy occurs in patients with alcoholic steatohepatitis and promotes inflammation and fibrosis

New Publication
Erythrocyte-derived microvesicles induce arterial spasms in JAK2V617F myeloproliferative neoplasm

Our lab received the "EMERGENCE grant" by the city of Paris for the project “Predicting Outcome of patients with cirrhosis using circulating extracellular Vesicles”

Pierre-Emmanuel RAUTOU obtained the ATIP AVENIR funding which allows young scientists to create and lead a team within an established Inserm laboratory in France in January 2019

Role of vessels in liver diseases